1. CPMP Note for Guidance on the Investigation of Bioavailability and Bioequivalence (CPMP/EMP/QWP/1401/98 Draft), December 1998.
2. Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms;Fagerholm;J. Pharm. Pharmacol.,1997
3. FDA Guidance for Industry Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System (CDER, FDA), August 2000.
4. Colonic drug targeting;Kinget;J. Drug Target.,1998
5. Motulski, H., 1995. Intuitive Biostatistics. Oxford University Press Inc, New York, pp. 255–262.